CapVest to acquire a majority stake in STADA from Bain Capital and Cinven at a €10bn valuation.

CapVest, a mid-market private equity firm agreed to acquire a majority stake in STADA, a healthcare and pharmaceuticals company specializing in consumer healthcare, generics and specialty pharmaceuticals, from Bain Capital and Cinven, at a €10bn valuation. “We have admired STADA for several years, including its deep heritage, leading product portfolio and a culture underpinned by caring for people's health. Peter and the entire STADA team have a best-in-class track record of performance. STADA is a unique strategic platform through which we will leverage our significant healthcare and consumer expertise to accelerate the development of the company in Germany and internationally. We intend to deploy significant new capital towards this objective. We look forward to working with Peter Goldschmidt and his team as custodians of this great company in its next phase of development,” Matthew Fargie, CapVest Principal.